不要放弃生物仿制药——国会可以推动它们:在活细胞中生长的药物很难复制。但政策变化有助于加速这一进程。

IF 1.4 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
American Health and Drug Benefits Pub Date : 2019-09-01
Scott Gottlieb
{"title":"不要放弃生物仿制药——国会可以推动它们:在活细胞中生长的药物很难复制。但政策变化有助于加速这一进程。","authors":"Scott Gottlieb","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":48595,"journal":{"name":"American Health and Drug Benefits","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979050/pdf/ahdb-12-252.pdf","citationCount":"0","resultStr":"{\"title\":\"Don't Give Up on Biosimilars-Congress Can Give Them a Boost: Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the process.\",\"authors\":\"Scott Gottlieb\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":48595,\"journal\":{\"name\":\"American Health and Drug Benefits\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2019-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979050/pdf/ahdb-12-252.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Health and Drug Benefits\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Health and Drug Benefits","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。

Don't Give Up on Biosimilars-Congress Can Give Them a Boost: Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the process.

Don't Give Up on Biosimilars-Congress Can Give Them a Boost: Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the process.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Health and Drug Benefits
American Health and Drug Benefits Medicine-Health Policy
CiteScore
2.90
自引率
0.00%
发文量
4
期刊介绍: AHDB welcomes articles on clinical-, policy-, and business-related topics relevant to the integration of the forces in healthcare that affect the cost and quality of healthcare delivery, improve healthcare quality, and ultimately result in access to care, focusing on health organization structures and processes, health information, health policies, health and behavioral economics, as well as health technologies, products, and patient behaviors relevant to value-based quality of care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信